These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7617693)

  • 1. NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats.
    Ogasawara T; Ukai Y; Tamura M; Kimura K
    Pharmacol Biochem Behav; 1995 Apr; 50(4):499-503. PubMed ID: 7617693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NS-3(CG3703), a TRH analog, ameliorates scopolamine-induced memory disruption in rats.
    Ogasawara T; Nakagawa Y; Ukai Y; Tamura M; Kimura K
    Pharmacol Biochem Behav; 1995 Aug; 51(4):929-34. PubMed ID: 7675879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems.
    Ogasawara T; Itoh Y; Tamura M; Ukai Y; Yoshikuni Y; Kimura K
    Pharmacol Biochem Behav; 1996 Feb; 53(2):391-9. PubMed ID: 8808149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NS-3, a TRH analog, reverses repeated ECS-induced deficits in water maze performance in the rat.
    Khan A; Lai H; Ukai Y; Mirolo MH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):477-81. PubMed ID: 8208765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.
    Yamamoto M; Shimizu M
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):262-7. PubMed ID: 3143078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinami de, as studied by intracerebral microdialysis.
    Itoh Y; Ogasawara T; Yamazaki A; Ukai Y; Miura A; Kimura K
    J Pharmacol Exp Ther; 1994 Jan; 268(1):255-61. PubMed ID: 8301565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thyrotropin-releasing hormone and its analogue, NS-3, on blood pressure, heart rate, and serum catecholamine levels in rats.
    Shinozuka K; Shimoura K; Hattori K
    Gen Pharmacol; 1997 Feb; 28(2):209-14. PubMed ID: 9013196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
    Itoh Y; Ogasawara T; Mushiroi T; yamazaki A; Ukai Y; Kimura K
    J Pharmacol Exp Ther; 1994 Nov; 271(2):884-90. PubMed ID: 7965809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thyrotropin-releasing hormone on behavioral disturbances in middle cerebral artery-occluded rats.
    Yamamoto M; Tamura A; Kirino T; Shimizu-Sasamata M; Sano K
    Eur J Pharmacol; 1991 May; 197(2-3):117-23. PubMed ID: 1915564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
    Yamamoto M; Ozawa Y; Takeuchi H
    Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory deficits following internal capsule lesions in rats and their improvement by L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide (RGH-2202), a thyrotropin-releasing hormone analogue.
    Oka M; Ito T; Furukawa K; Karasawa T; Kadokawa T
    Arch Int Pharmacodyn Ther; 1990; 306():18-33. PubMed ID: 1981666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer.
    Ogasawara T; Itoh Y; Tamura M; Mushiroi T; Ukai Y; Kise M; Kimura K
    Pharmacol Biochem Behav; 1999 Sep; 64(1):41-52. PubMed ID: 10494996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of TRH and its analog (NS-3) in thermoregulatory and cardiovascular effects.
    Huang XC; Saigusa T; Iriki M
    Peptides; 1992; 13(2):305-11. PubMed ID: 1409009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats.
    Yamamura M; Kinoshita K; Nakagawa H; Ishida R
    Jpn J Pharmacol; 1991 Feb; 55(2):241-53. PubMed ID: 1906119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of RGH 2202 on cognitive and motor behavior of the rat.
    Drago F; Coppi G; Antonuzzo PA; Valerio C; Genazzani AA; Grassi M; Raffaele R; Scapagnini U
    Neurobiol Aging; 1996; 17(1):67-71. PubMed ID: 8786805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
    Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
    J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new TRH analogue, YM-14673, on disturbance of passive avoidance learning in senescence-accelerated mice.
    Yamamoto M; Iwai A; Ozawa Y
    Pharmacol Biochem Behav; 1990 Mar; 35(3):727-9. PubMed ID: 2111030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interaction with cholinergic drugs in reversal of cycloheximide-induced amnesia by thyrotropin-releasing hormone and its analog DN-1417 in mice].
    Yamazaki N; Shintani M; Saji Y; Nagawa Y
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):127-36. PubMed ID: 6431710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.